Company profile for Origin Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Origin Therapeutics (CSE: ORIG) is an actively-managed investment issuer providing investors with diverse exposure to the psychedelic industry. Our investment mandate is simple: focus on companies with an exemplary management team and exponential growth profile.A Global Psychedelic-Focused Investment Opportunity Origin Therapeutics is an actively-managed investment issuer providing investors with a diverse exposure to the p...
Origin Therapeutics (CSE: ORIG) is an actively-managed investment issuer providing investors with diverse exposure to the psychedelic industry. Our investment mandate is simple: focus on companies with an exemplary management team and exponential growth profile.A Global Psychedelic-Focused Investment Opportunity Origin Therapeutics is an actively-managed investment issuer providing investors with a diverse exposure to the psychedelic industry.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Canada
Address
Address
505 Burrard St, Suite 1570, Vancouver, British Columbia V7X 1M3
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

34th NZW-Hamburg

Not Confirmed

envelop Contact Supplier

34th NZW-Hamburg

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2023/09/12/2741226/0/en/SAFE-SUPPLY-AND-ORIGIN-THERAPEUTICS-RECEIVE-CONDITIONAL-APPROVAL-FOR-LISTING-ON-THE-CSE.html

GLOBENEWSWIRE
11 Sep 2023

https://www.globenewswire.com/news-release/2023/08/02/2717134/0/en/SAFE-SUPPLY-AND-ORIGIN-THERAPEUTICS-ANNOUNCE-SIGNING-OF-DEFINITIVE-AGREEMENT.html

GLOBENEWSWIRE
02 Aug 2023

https://www.globenewswire.com/news-release/2023/08/02/2717126/0/en/Origin-Therapeutics-Announces-Closing-of-Safe-Supply-Subscription-Receipt-Financing.html

GLOBENEWSWIRE
02 Aug 2023

https://www.globenewswire.com/news-release/2023/03/02/2619733/0/en/SAFE-SUPPLY-AND-ORIGIN-THERAPEUTICS-ANNOUNCES-ENGAGEMENT-OF-RESEARCH-CAPITAL-AND-UPSIZING-OF-BROKERED-FINANCING-TO-4-MILLION.html

GLOBENEWSWIRE
02 Mar 2023

https://www.globenewswire.com/news-release/2023/01/31/2598932/0/en/Origin-Enters-into-Binding-Letter-of-Intent-with-Safe-Supply-Streaming-Co-a-Pharmaceutical-and-Narcotics-Investment-Company-with-a-First-Mover-Advantage-in-the-Safe-Supply-Narcotic.html

GLOBENEWSWIRE
31 Jan 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty